Navigation Links
Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
Date:11/6/2007

/p>

indicated that a future New Drug Application filing for this product

candidate could be eligible to receive priority review. The company

plans to initiate a Phase II clinical trial in the fourth quarter of

2007.

-- Interim data have been obtained from two single dose studies, one in

healthy volunteers and one in epilepsy patients, of JZP-4, a product

candidate for the treatment of partial epilepsy and bipolar disorder.

The data from both of these studies indicate biological activity in

human epilepsy models. A single dose study of a controlled-release

formulation of JZP-4 is underway, and is expected to complete in the

fourth quarter of 2007. Jazz Pharmaceuticals plans to initiate

Phase II clinical trial activities for JZP-4 by the end of 2007.

-- A second pharmacokinetic study of JZP-7, a product candidate for the

treatment of restless legs syndrome, was initiated in the third quarter

of 2007, and Jazz Pharmaceuticals expects top line results from that

study in the second quarter of 2008.

-- In August 2007, the U.S. Patent and Trademark Office (USPTO) awarded

Jazz Pharmaceuticals a new U.S. patent (No. 7,262,219) titled

"Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate

Salt for the Treatment of Narcolepsy." This Xyrem patent is now listed

in the FDA's Orange Book.

Jazz Pharmaceuticals will host an investor conference call and live audio webcast to discuss its quarterly results on November 6, 2007 at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time. The live webcast and press release may be accessed on Jazz Pharmaceuticals' website at http://www.JazzPharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that m
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Deer Path of Huntley -- ... Day Happy Hour from 3 p.m. to 4 p.m. on Feb. ... in Huntley, Illinois, serves adults with physical disabilities between the ages ... Valentine's Day treats, games and sweetheart-themed karaoke. , For more information ...
(Date:1/22/2015)... California (PRWEB) January 22, 2015 The City of ... at 10 a.m., to commemorate the 42nd anniversary of the Supreme ... States. , “It’s been 42 years since the Roe vs. Wade ... is still as present as ever,” said City of West Hollywood ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader ... designers are thrilled to have it lead the wedding dress ... collection of prom dresses for the global market. , “The ... vision and he focuses on continuing the goal of operational ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently released ... website of AngelWeddingDress.com to find more details. , ... for a bridal party. AngelWeddingDress offers a variety of ... maternity wedding dresses are specially designed for 2015. , ...
(Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... WASHINGTON, July 31 Speaker Nancy Pelosi issued the following statement ... to pass the America,s Affordable Health Choices Act, the third House ... and Means Committee and Education and Labor Committee approved the bill ... than 60 years, we have tried as a nation to make ...
... , WASHINGTON, July 31 ... "The Importance of a Cost Control Enforcement Entity In ... President Obama,s proposed Independent Medicare Advisory Council (IMAC). The ... experts who would routinely review Medicare spending and provide ...
... childhood cancer neuroblastoma are eight times more likely to ... and more likely to have lower incomes than their ... in the Journal of the National Cancer Institute ... exists on the long-term outcomes for neuroblastoma survivors. ...
... Hanger Orthopedic Group, Inc. (NYSE: HGR ) is ... Hanger Orthopedic Group, Inc. to "B1" from "B2." Moody,s also ... "Ba2" from "Ba3" and senior unsecured debt to "B3" from "Caa1." ... , "We are extremely pleased with the Moody,s upgrade ...
... , WASHINGTON, July 31 On behalf ... Kathleen Novak, mayor, Northglenn, Colo., commends President Barack Obama, the ... Pensions Committee for making progress on efforts to enact legislation ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NLCLOGO ) , ...
... and social issues years later , FRIDAY, July 31 (HealthDay ... long-term health and social problems, according to a new study. ... been diagnosed with neuroblastoma -- a cancer that forms in ... with data on 3,899 siblings of children with cancer. Twenty ...
Cached Medicine News:Health News:Concord Coalition Releases Issue Brief on Administration's IMAC Proposal 2Health News:Long-term health and social outcomes for neuroblastoma survivors 2Health News:Hanger Orthopedic Group, Inc. Receives Upgrade From Moody's Investors Service 2Health News:National League of Cities Commends President and Congress on Work Towards Health Care Reform 2
(Date:1/23/2015)... Jan. 23, 2015  Today the U.S. Food and Drug ... the prevention of serogroup B meningococcal disease ... vaccine Trumenba®, which received FDA approval in October, represent ... disease. "I have heard over and ...
(Date:1/23/2015)... WASHINGTON , Jan. 23, 2015  A new analysis ... Part D 2015 enrollment data shows that 81 percent ... convenient access and extra discounts at certain pharmacies. The ... "Preferred pharmacy plans are now the foundation of ...
(Date:1/23/2015)... Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) ... of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... its fiduciary duties to shareholders. On January ... website reporting that Advaxis had misrepresented the clinical data ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... Calif., Oct. 21 Bionovo, Inc. (Nasdaq: ... of results from studies discussing new classes of estrogen ... The review is published in the most recent edition ... is entitled, "Regulation of Specific Target Genes and Biological ...
... has granted The Lanier Law Firm ,s motion for a ... cases in In re: DePuy Orthopaedics Inc. ASR Hip Implant ... The United States Judicial Panel on Multidistrict Litigation granted the ... DePuy hip implant litigation for Nov. 18, 2010, at Duke University ...
Cached Medicine Technology:Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions 2Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions 3Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions 4Federal Panel Grants Lanier Law Firm Motion for Hearing on National Coordination of DePuy Hip Implant Lawsuits 2
... ScImage's PICOMEnterprise is a web-enabled ... custom reporting and custom workflow integration. ... captures, stores, distributes and archives images, ... any DICOM and many non-DICOM devices ...
... Blood Pressure Monitoring System (ABPM) allows health ... blood pressure throughout the day. ABPM therapy ... hypertension and the data generated can be ... compact monitor has sophisticated tracking capabilities to ...
... AutoPulse Resuscitation System consists of the portable ... and a rechargeable battery pack with a ... designed for adults with weight up to ... to 51.2 inches (76 to 130 cm) ...
... single information technology platform, the VERICIS ... from different sites (office, clinic, hospital) ... x-ray angiography, echo, nuclear, MR, hemodynamics, ... digital record on the cardiac patient. ...
Medicine Products: